S. aureus clinical (n = 27) | S. aureus community (n = 13) | |||||
ATBs tested | R (%) | I (%) | S (%) | R (%) | I (%) | S (%) |
CIP | 19 (70.37%) | 0 (%) | 8 (29.62%) | 9 (69.23%) | 0 (0%) | 4 (30.76%) |
NOR | 19 (70.37%) | 0 (%) | 8 (29.62%) | 8 (61.53%) | 0 (0%) | 5 (38.46%) |
LEV | 16 (59.25% | 0 (%) | 11 (40.74%) | 8 (61.53%) | 0 (0%) | 5 (38.46%) |
OFL | 21 (77.77%) | 0 (%) | 6 (22.22%) | 8 (61.53%) | 0 (0%) | 5 (38.46%) |
MOX | 12 (44.44%) | 0 (%) | 15 (55.55%) | 6 (46.15%) | 0 (0%) | 7 (53.84%) |
A N | 26 (96.29%) | 0 (%) | 1 (3.70%) | 13 (100%) | 0 (0%) | 0 (0%) |